Table 4

Whole gut and regional transit times (median (IQR))

Whole gut transit timeRight colonLeft colonRectosigmoid
Healthy controls N=1946 (12–58)13 (5–18)12 (3–24)7 (4–15)
Patients with IBS-D on placebo16 (7–29)*6 (2–12)2.5 (0–7)***4 (1–9)***
Patients with IBS-D on ondansetron24 (15–47)7 (3–16)6 (0–17.25)7 (2–13)
P for difference on ondansetronNS<0.05<0.05
  • *p<0.05, ***p<0.001 versus healthy volunteers.

  • IBS-D, irritable bowel syndrome with diarrhoea.